GeneDx Holdings Corp. (WGS) Stock Analysis

GeneDx Holdings Corp. (WGS) is a publicly traded company in the HEALTHCARE sector. It trades at $53.13, carries a market capitalization of $1.54B. This page summarizes the public market data, fundamentals, and frequently asked questions for WGS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $53.13
• Market Cap: $1.54B
• EPS: $-2.66
• 52-Week High: $170.87
• 52-Week Low: $32.21

Market Sentiment

GeneDx Holdings Corp. currently has a Bullish sentiment score of 0.23.

About GeneDx Holdings Corp.

GeneDx Holdings Corp., headquartered in Stamford, Connecticut, stands at the forefront of genomic diagnostics, emphasizing precision medicine through its advanced genetic testing solutions. The company is dedicated to providing groundbreaking diagnostic services that deepen the understanding of genetic conditions, thereby empowering healthcare providers and patients to make informed choices. With a diverse array of tests and a strong focus on technological integration, GeneDx is strategically...

GNG Research Analysis

GNG Research scores GeneDx Holdings Corp. (WGS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for WGS.

Frequently Asked Questions

Does WGS pay dividends?

GeneDx Holdings Corp. (WGS) does not currently pay a regular dividend.

What is WGS's market cap?

GeneDx Holdings Corp. (WGS) has a market capitalization of $1.54B with a current stock price of $53.13.